This disclosure relates to medical fluid pump systems and related components and methods.
Dialysis is a treatment used to support a patient with insufficient renal function. The two principal dialysis methods are hemodialysis and peritoneal dialysis.
During hemodialysis (“HD”), the patient's blood is passed through a dialyzer of a dialysis machine while also passing a dialysis solution or dialysate through the dialyzer. A semi-permeable membrane in the dialyzer separates the blood from the dialysate within the dialyzer and allows diffusion and osmosis exchanges to take place between the dialysate and the blood stream. These exchanges across the membrane result in the removal of waste products, including solutes like urea and creatinine, from the blood. These exchanges also regulate the levels of other substances, such as sodium and water, in the blood. In this way, the dialysis machine acts as an artificial kidney for cleansing the blood.
During peritoneal dialysis (“PD”), the patient's peritoneal cavity is periodically infused with sterile aqueous solution, referred to as PD solution or dialysate. The membranous lining of the patient's peritoneum acts as a natural semi-permeable membrane that allows diffusion and osmosis exchanges to take place between the solution and the blood stream. These exchanges across the patient's peritoneum result in the removal waste products, including solutes like urea and creatinine, from the blood, and regulate the levels of other substances, such as sodium and water, in the blood.
Many PD machines are designed to automatically infuse, dwell, and drain dialysate to and from the patient's peritoneal cavity. The treatment typically lasts for several hours, often beginning with an initial drain cycle to empty the peritoneal cavity of used or spent dialysate. The sequence then proceeds through the succession of fill, dwell, and drain phases that follow one after the other. Each phase is called a cycle.
In one aspect of the invention, a medical fluid pump system includes a movable piston head and a cassette. The cassette includes a base defining an opening and a membrane attached to the base covering the opening. The membrane together with the base define a fluid pump chamber, a flow pathway that leads from the fluid pump chamber to an inlet of the cassette, and a flow pathway that leads from the fluid pump chamber to an outlet of the cassette. The cassette is positioned so that the membrane faces the piston head and can be moved by the piston head to change a volume of the fluid pump chamber. An adhesive is disposed between and in contact with the piston head and the membrane. The adhesive has sufficient affinity for the piston head to allow the piston head to retract and deflect the membrane outward to increase the volume of the fluid pump chamber while maintaining adhesive contact with the membrane. The adhesive has substantially greater affinity for the membrane than for the piston head such that the piston head can be retracted in a manner to separate the piston head from the adhesive without separating the adhesive from the membrane.
In another aspect of the invention, a medical fluid delivery cassette includes a base defining an opening and a membrane attached to the base covering the opening. The membrane together with the base define a fluid pump chamber, a flow pathway that leads from the fluid pump chamber to an inlet of the cassette, and a flow pathway that leads from the fluid pump chamber to an outlet of the cassette. A portion of the membrane overlying the fluid pump chamber is moveable relative to the base such that the volume of the fluid pump chamber can be changed by applying a force to the portion of the membrane overlying the fluid pump chamber. An adhesive coating is disposed on an outside surface of the portion of the membrane overlying the fluid pump chamber, and a release layer substantially covers and is releasably attached to the adhesive coating.
In an additional aspect of the invention, a medical fluid delivery method includes adhering a first piston head of a medical system to a membrane of a medical fluid delivery cassette by moving the first piston head into contact with adhesive disposed on a portion the membrane overlying a first fluid pump chamber, and, with the first piston head adhered to the membrane, changing a volume of the first fluid pump chamber by flexing the portion of the membrane overlying the first fluid pump chamber with the first piston head.
Implementations can include one or more of the following features.
In some implementations, the piston head is adapted to be moved away from the cassette with a force sufficient to overcome the affinity between the piston head and the adhesive such that the piston head can be separated from the membrane.
In certain implementations, the piston head is arranged to be moved a distance of at least 1.5 centimeters away from a plane in which the membrane lies when the membrane is not deformed by the piston head.
In some implementations, the system includes a wall adjacent the cassette, and the piston head can be retracted beyond an outer surface of the wall.
In certain implementations, the piston head includes (e.g., is formed of) polyoxymethylene and the membrane includes (e.g., is formed of) a low density polyolefin.
In some implementations, the adhesive includes (e.g., is formed of) synthetic rubber (e.g., a double coated synthetic rubber tape).
In certain implementations, an adhesion strength of the adhesive to polyester is about 89 Oz./in. (about 97 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour RT).
In some implementations, an adhesion strength of the adhesive to polypropylene is about 85 Oz./in. (about 93 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour RT).
In certain implementations, an adhesion strength of the adhesive to polycarbonate is about 101 Oz./in. (about 110 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour RT).
In some implementations, an adhesion strength of the adhesive 161 to stainless steel is about 97 Oz./in. (about 106 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour RT).
In certain implementations, an adhesion strength of the adhesive to the membrane is substantially greater than an adhesion strength of the adhesive to the piston head.
In some implementations, the adhesive includes a first layer of adhesive in contact with the membrane and a second layer of adhesive in contact with the piston head.
In certain implementations, the medical fluid pump system further includes a base layer (e.g., a substantially liquid impermeable base layer) disposed between the first and second layers of adhesive.
In some implementations, the first layer of adhesive is biocompatible and the second layer of adhesive is bioincompatible.
In certain implementations, the piston head is movable in a direction substantially perpendicular to the cassette.
In some implementations, the piston head can be separated from the adhesive by moving the piston head in the direction substantially perpendicular to the cassette.
In certain implementations, the piston head is configured to be rotated relative to the cassette.
In some implementations, the piston head can be separated from the adhesive by rotating the piston head relative to the cassette.
In certain implementations, the base of the cassette is a molded tray-like base.
In some implementations, the adhesive is disposed on a portion of the membrane overlying the fluid pump chamber.
In certain implementations, the adhesive is substantially uniformly disposed on the portion of the membrane overlying the fluid pump chamber.
In some implementations, the medical system includes first and second movable piston heads, and the membrane together with the base defines first and second fluid pump chambers, flow pathways that lead from the first and second fluid pump chambers to the inlet of the cassette, and flow pathways that lead from the first and second fluid pump chambers to the outlet of the cassette. The cassette is positioned so that the membrane faces the first and second piston heads and can be moved by the first and second piston heads to alter volumes of the first and second fluid pump chambers, and adhesive is disposed between and in contact with the first and second piston heads and the membrane. The adhesive has sufficient affinity for the first and second piston heads to allow the first and second piston heads to retract and deflect the membrane outward to increase the volumes of the first and second fluid pump chambers while maintaining adhesive contact with the membrane. The adhesive has substantially greater affinity for the membrane than for the first and second piston heads such that the first and second piston heads can be retracted in a manner to separate the first and second piston heads from the adhesive without separating the adhesive from the membrane.
In certain implementations, the medical fluid pump system is a dialysis system (e.g., a peritoneal dialysis system).
In some implementations, the adhesive coating is produced by applying the release layer carrying adhesive to the membrane.
In certain implementations, the release layer is release paper (e.g., a wax-coated paper).
In some implementations, the adhesive coating is disposed on a portion of the membrane that is contacted by a piston head of a medical fluid pump system during use.
In certain implementations, the release layer is removable from the adhesive coating to expose at least a portion of the adhesive coating.
In some implementations, the release layer includes a pull tab that extends beyond an outer boundary of the adhesive.
In certain implementations, the membrane includes a low density polyolefin.
In some implementations, the medical fluid delivery cassette is configured for use with a dialysis machine (e.g., a peritoneal dialysis machine).
In certain implementations, the medical fluid delivery cassette is disposable.
In some implementations, the adhesive coating has a greater affinity for the membrane than for a piston head of a medical fluid pumping system when the cassette is in use with the medical fluid pumping system such that the piston head can be retracted in a manner to separate the piston head from the adhesive without separating the adhesive from the membrane.
In certain implementations, the adhesive coating includes first and second layers of adhesive, and the first layer of adhesive is in contact with the membrane.
In some implementations, the adhesive has a greater affinity for the membrane than for the first piston head such that the first piston head can be retracted in a manner to separate the first piston head from the adhesive without separating the adhesive from the membrane.
In certain implementations, flexing the portion of the membrane overlying the first fluid pump chamber includes moving the first piston head away from the cassette with a force that does not exceed the affinity between the membrane and the adhesive.
In some implementations, the medical fluid delivery method further includes decoupling the first piston head from the membrane by moving the first piston head relative to the cassette.
In certain implementations, the adhesive remains attached to the membrane after decoupling the first piston head from the membrane.
In some implementations, the medical fluid delivery method further includes decoupling the first piston head from the membrane by moving the piston head in a direction substantially perpendicular to the cassette.
In certain implementations, the medical fluid delivery method further includes decoupling the first piston head from the membrane by rotating the piston head relative to the cassette.
In some implementations, the medical fluid delivery method further includes adhering a second piston head to the membrane by moving the second piston head into contact with adhesive disposed on a portion of the membrane overlying a second fluid pump chamber and, with the second piston head adhered to the membrane, changing a volume of the second fluid pump chamber by flexing the portion of the membrane overlying the second fluid pump chamber with the second piston head.
In certain implementations, the medical fluid delivery method further includes disposing the adhesive on the membrane by applying a release layer carrying adhesive to the membrane.
In some implementations, the medical fluid delivery method further includes removing the release layer from the adhesive.
In certain implementations, removing the release layer includes pulling on a pull tab of the release paper, where the pull tab extends beyond an outer boundary of the adhesive prior to removing the release layer from the adhesive.
Implementations can include one or more of the following advantages.
In some implementations, the PD system includes an adhesive disposed between the piston head and the membrane. This arrangement permits the piston head to be moved in a direction away from the cassette to draw dialysate into the cassette without extensive use of a vacuum system. For example, while the PD system may include a vacuum system to deflate inflatable valves that are used to direct fluid through desired pathways of the cassette, the membrane of the cassette in the region of the pump chamber can be attached to the piston head using only adhesive. By using adhesive, as opposed to vacuum pressure, to secure the membrane of the cassette to the piston head, the likelihood of fluid being pulled through the membrane (e.g., through very small holes in the membrane) is substantially reduced or eliminated. Additionally or alternatively, the level of noise produced by the PD system during operation can be substantially reduced relative to certain prior PD systems that use vacuum pressure retract the cassette membrane in the region of the pump chamber as the piston head is retracted. In addition, the use of adhesive to secure the membrane of the cassette to the piston head can reduce the overall cost and complexity of manufacturing the PD system.
In certain implementations, the piston head is adhesively attached to the membrane of the cassette and can draw the membrane away from the cassette to draw dialysate into the cassette. The adhesive attachment between the piston head and the membrane can result in a substantially direct correlation between the piston head position and the volume drawn into the cassette. Thus, adhesively attaching the piston head to the membrane can improve the speed and accuracy of volumetric calculations of dialysate drawn into the cassette. Additionally or alternatively, if any holes (e.g., pinholes) were to develop in the portion of the membrane to which the adhesive is attached, the adhesive could act as a seal and thus reduce the likelihood that fluid will leak out of the cassette.
In certain implementations, the adhesion strength or affinity of the adhesive to the membrane of the cassette is greater than the adhesion strength or affinity of the adhesive to the piston head. In such a configuration, the piston head can be moved away from the membrane by a sufficient distance and with a sufficient force to detach the piston head from the adhesive without detaching the adhesive from the membrane. The piston head can, for example, be retracted with a force greater than the adhesion strength of the adhesive to the piston head but less than the adhesion strength of the adhesive to the membrane of the cassette to detach the piston head from the adhesive while retaining the attachment between the adhesive and the membrane of the cassette. The particular material properties of the adhesive, cassette membrane, and piston head inhibit or eliminate adhesive from remaining attached to the piston head upon detachment of the piston head from the membrane and can thus reduce or prevent adhesive build-up in the PD system over time.
In some implementations, the cassette is disposable. In such implementations, the cassette, along with adhesive retained on the cassette, can be discarded after use. Such a disposable cassette can reduce the need for the user to remove or otherwise handle the adhesive.
In certain implementations, a release layer (e.g., a release paper) covers and is releasably attached to adhesive on the cassette. The release layer can be removed to expose the adhesive before use. The release layer can help to prevent debris and contaminants from collecting on the adhesive prior to use of the cassette.
Other aspects, features, and advantages will be apparent from the description and drawings, and from the claims.
Referring to
PD solution bags 122 are suspended from fingers on the sides of the cart 104, and a heater bag 124 is positioned in the heater tray 116. The PD solution bags 122 and the heater bag 124 are connected to the cassette 112 via PD solution bag lines 126 and a heater bag line 128, respectively. The PD solution bag lines 126 can be used to pass PD solution from PD solution bags 122 to the cassette 112 during use, and the heater bag line 128 can be used to pass PD solution back and forth between the cassette 112 and the heater bag 124 during use. In addition, a patient line 130 and a drain line 132 are connected to the cassette. The patient line 130 can be connected to a patient's abdomen via a catheter and can be used to pass PD solution back and forth between the cassette 112 and the patient during use. The drain line 132 can be connected to a drain or drain receptacle and can be used to pass PD solution from the cassette 112 to the drain or drain receptacle during use.
The PD cycler 102 also includes multiple inflatable members 142 positioned within inflatable member access ports 144 in the cassette interface 110. The inflatable members 142 align with depressible dome regions 146 of the cassette 112 when the cassette 112 is positioned within the cassette enclosure 114. While only one of the inflatable members 142 is labeled in
Still referring to
The door 108 defines recesses 152A, 152B that substantially align with the piston heads 134A, 134B when the door 108 is in the closed position. When the cassette 112 is positioned within the cassette enclosure 114, hemispherical projections 154A, 154B of the cassette 112 (shown in
The PD cycler 102 includes various other features not described here. Further details regarding the PD cycler 102 and its various components can be found in U.S. Patent Application Publication No. 2007/0112297, which is incorporated by reference herein.
Referring to
The rigidity of the base 156 helps to hold the cassette 112 in place within the cassette enclosure 114 of the PD cycler 102 and to prevent the hemispherical projections 154A, 154B and the other raised features of the cassette 112 from flexing and deforming in response to changes in pressure within the cassette 112 during use. The rigidity of the base 156 also allows the hemispherical projections 154A, 154B to resist deformation by the piston heads 134A, 134B during use.
The fluid pathways 158 in the cassette 112 lead from the pumping chambers 138A, 138B to connectors 160 positioned along the bottom edge of the cassette 112. The connectors 160 are positioned asymmetrically along the width of the cassette 112. The asymmetrical positioning of the connectors 160 helps to ensure that the cassette 112 will be properly positioned in the cassette enclosure 114 with the membrane 140 and of the cassette 112 facing the cassette interface 110. The connectors 160 are configured to receive fittings on the ends of the PD solution bag lines 126, the heater bag line 128, the patient line 130, and the drain line 132. These fittings are double male fittings. One end of the fitting can be inserted into and bonded to its respective line and the other end can be inserted into and bonded to its associated connector 160. By permitting the PD solution bag lines 126, the heater bag line 128, the patient line 130, and the drain line 132 to be connected to the cassette, as shown in
Still referring to
Adhesive 161 is disposed on regions 162A, 162B of the membrane 140 that overlie the pump chambers 138A, 138B. The adhesive 161 is a double coated synthetic rubber adhesive tape manufactured by 3M as part number 9443NP. The properties of the adhesive 161 allow the adhesive 161 to achieve a temporary adhesive attachment with the piston heads 134A, 134B when the piston heads 134A, 134B are brought into contact with the adhesive regions during use. The attachment between the adhesive 161 and the piston heads 134A, 134B is sufficiently strong to allow the adhesive to remain attached to the piston heads 134A, 134B as the piston heads 134A, 134B are reciprocated during use. At the same time, the attachment between the adhesive 161 and the piston heads 134A, 134B can be readily broken by retracting the piston heads 134A, 134B by a greater distance than they are retracted during treatment and with a force that exceeds the adhesion force between the adhesive 161 and the piston heads 134A, 134B.
The adhesion strength of the adhesive 161 to polyester is about 89 Oz./in. (about 97 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour room temperature (RT)). The adhesion strength of the adhesive 161 to polypropylene is about 85 Oz./in. (about 93 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour RT). The adhesion strength of the adhesive 161 to polycarbonate is about 101 Oz./in. (about 110 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour RT). The adhesion strength of the adhesive 161 to stainless steel is about 93 Oz./in. (about 101 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 15 minute RT). The adhesion strength of the adhesive 161 to stainless steel is about 97 Oz./in. (about 106 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour RT). The adhesion strength of the adhesive 161 to stainless steel is about 126 Oz./in. (about 137 N/100 mm), as tested using the ASTM D3330 test (90 degree, 2 mil Al foil, 72 hour 158° F. (70° C.)). The adhesion strength of the adhesive 161 to stainless steel is about 206 Oz./in. (about 224 N/100 mm), as tested using the ASTM D3330 test (180 degree, 2 mil Al foil, 72 hour RT).
During use, the cassette 112 is secured within the cassette enclosure 114 by positioning the adhesive-carrying side of the cassette 112 adjacent to the cassette interface 110 of the PD cycler 102 and closing the door 108 over the cassette 112. As noted above, the piston heads 134A, 134B align with the pump chambers 138A, 138B of the cassette 112 when the cassette 112 is positioned in the cassette enclosure 114 between the cassette interface 110 and the closed door 108. Thus, with the cassette 112 secured in the cassette enclosure 114, the piston heads 134A, 134B can extend into the enclosure 114 to contact the adhesive 161 disposed on regions 162A, 162B of the flexible membrane 140 and become temporarily adhesively attached to the membrane 140 of the cassette 112. The adhesive 161, the material of the piston heads 134A, 134B, and the material of the membrane 140 are selected so that the adhesive 161 has a greater adhesion or affinity to the membrane 140 than to the piston heads 134A, 134B. The adhesive attachment between the piston heads 134A, 134B and the membrane 140 causes the regions 162A, 162B of the membrane 140 overlying the pump chambers 138A, 138B to move along with the piston heads 134A, 134B, and thus allows PD solution to be drawn into or forced out of the pump chambers of the cassette 112 in response to piston head movement during treatment. Movement of those regions 162A, 162B of the membrane 140 overlying the pump chambers 138A, 138B (e.g., through movement of piston heads 134A, 134B) changes the internal volume of the pump chambers 138A, 138B. For example, movement of the membrane 140 toward the rigid base 156 decreases the fluid volume stored in each of the pump chambers 138A, 138B, and thus forces some of the PD solution out of the cassette 112 during treatment. Similarly, movement of the membrane 140 away from the base 156 increases the fluid volume stored in the pump chambers 138A, 138B, and thus draws PD solution into the cassette 112 during treatment.
By retracting the piston heads 134A, 134B farther than they are retracted during treatment (i.e., farther than they are retracted to draw fluid into the pump chambers 138A, 138B during treatment) and with a force that exceeds the adhesion force between the piston heads 134A, 134B and the adhesive 161, the piston heads 134A, 134B can be detached from the adhesive 161 and the membrane 140. The piston heads 134A, 134B can, for example, be fully retracted into the piston access ports 136A, 136B to detach the piston heads 134A, 134B from the adhesive 161 and the membrane 140. In some cases, the piston heads 134A, 134B are retracted at least about 1.0 centimeters (e.g., at least about 1.5 centimeters, about 1.0 centimeters to about 2.5 centimeters, about 1.5 centimeters) away from the plane in which the membrane 140 lies in its undeformed state with the cassette 112 positioned in the cassette enclosure 114. Retracting the piston heads 134A, 134B to this position can help to ensure that the piston heads 134A, 134B detach from the adhesive 161.
The movement of the piston heads 134A, 134B away from the cassette 112 exerts a tensile stress on the adhesive 161. The piston heads 134A, 134B remain substantially adhered to the adhesive 161 if the tensile forces exerted by the piston heads 134A, 134B are less than the adhesion strength of the adhesive 161 to the piston heads 134A, 134B and/or the piston heads 134A, 134B are retracted by a distance less than the distance required to detach the piston heads 134A, 134B from the adhesive 161. The piston heads 134A, 134B detach from the adhesive 161 if the tensile forces exerted by the piston heads 134A, 134B are greater than the adhesion strength of the adhesive 161 to the piston heads 134A, 134B and the piston heads 134A, 134B are retracted by a sufficient distance to detach the piston heads 134A, 134B from the adhesive 161.
To permit the piston heads 134A, 134B to be detached from the adhesive 161 while the adhesive 161 remains attached to the membrane 140 of the cassette 112, the adhesive 161, the piston heads 134A, 134B, and the membrane 140 are formed of materials such that the adhesion strength or affinity of the membrane 140 to the adhesive 161 is greater than the adhesion strength or affinity of the piston heads 134A, 134B to the adhesive 161. To reduce the likelihood that the adhesive 161 will detach from the membrane 140 (and remain attached to the piston heads 134A, 134B) while attempting to detach the piston heads 134A, 134B from the adhesive (i.e., by retracting the piston heads 134A, 134B), the adhesive 161, the piston heads 134A, 134B, and the membrane 140 are formed of materials such that the adhesion strength or affinity of the adhesive 161 to the membrane 140 is substantially greater (e.g., at least about two times greater (e.g., about two to about three times greater)) than the adhesion strength or affinity of the adhesive 161 to the piston heads 32A, 23B.
As a result of the selected materials of the adhesive 161, the piston heads 134A, 134B, and the membrane 140, the piston heads 134A, 134B can be detached from the adhesive 161 in a manner similar to that in which a 3M Post-It® note is detached from a surface (e.g., desktop or sheet of paper). The material selection can, for example, ensure that an insignificant amount of adhesive (e.g., no adhesive) remains attached to the piston heads 134A, 134B after the piston heads 134A, 134B are detached from the adhesive 161 and the membrane 140.
In some implementations, the adhesive 161 is capable of maintaining contact with the piston heads 134A, 134B for up to 24 hours at a pump speed of about 200 ml/min to about 600 ml/min.
In certain implementations, the adhesive 161 is disposed substantially uniformly over regions 162A, 162B. Such a substantially uniform distribution of the adhesive 161 can reduce the likelihood that the membrane 140 will separate or decouple from the piston heads 134A, 134B during normal operation. Additionally or alternatively, such a substantially uniform distribution of adhesive can improve the accuracy in calculating the volume of pump chambers 138A, 138B based on the position of the piston heads 134A, 134B, which can be used to closely track the volume of PD solution pumped out of and drawn into the pump chambers 138A, 138B during treatment.
In addition to securing the piston heads 134A, 134B to the membrane 140 of the cassette 112, the adhesive 161 can reduce the likelihood of fluid intrusion into the PD cycler 102 during use. For example, because the adhesive 161, rather than vacuum pressure, is used to retract the portions of the membrane 140 overlying the pump chambers 138A, 138B in order to draw fluid into the pump chambers 138A, 138B, the possibility of fluid being drawn through the membrane 140 as a result of excessive vacuum pressure is eliminated. In addition, in some cases, the adhesive 161 acts as a substantially impermeable layer that restricts (e.g., prevents) PD solution from passing through the cassette 112 into the PD cycler 102 in regions 162A, 162B. For example, to the extent that the membrane 140 is semi-permeable or becomes semi-permeable (e.g., through repeated flexing during use), the adhesive 161 can form a substantially liquid tight seal with the membrane 140 across regions 162A, 162B of the membrane 140.
As shown in
The release paper 164 includes two circular portions 166A, 166B and a connector portion 168 that extends between the two circular portions 166A, 166B. The circular portions 166A, 166B cover the adhesive laden regions 162A, 162B of the cassette membrane 140. The release paper 164 also includes a pull tab 170 that extends beyond the outer boundary of the adhesive 161 such that the pull tab 170 is not attached to the adhesive 161. A user can remove the release paper 164 to expose the adhesive 161 by pulling the pull tab 170. As the pull tab 170 is pulled away from the cassette 112, the connector portion 168 of the release paper 164 facilitates removal of both circular portions 166A, 166B of the release paper 164 through a single, continuous motion.
Referring to
As shown in
While loading the cassette 112 into the PD cycler 102, the piston heads 134A, 134B are completely retracted within the piston access ports 136A, 136B. This positioning of the piston heads 134A, 134B can reduce the likelihood of damage to the piston heads 134A, 134B during installation of the cassette 112. This positioning of the piston heads 134A, 134B can also facilitate positioning the cassette 112 against the cassette interface 110 before closing the door 108. For example, this positioning can help to ensure that the adhesive 161 is not inadvertently attached to the piston heads 134A, 134B prior to properly positioning the cassette 112 within the cassette enclosure 114.
Referring to
As shown in
With the piston heads 134A, 134B adhesively attached to the membrane 140, PD solution can be drawn into the pump chambers 138A, 138B of the cassette 112 by retracting the membrane 140 along with the piston heads 134A, 134B to increase the volume of the pump chambers 138A, 138B, as shown in
Referring back to
After draining the spent PD solution from the patient, heated PD solution is transferred from the heater bag 124 to the patient. To do this, the pump of the PD cycler 102 is activated to cause the piston heads 134A, 134B to reciprocate and certain inflatable members 142 of the PD cycler 102 are inflated to cause the spent PD solution to be drawn into the pump chambers 138A, 138B of the cassette 112 from the heater bag 124 via the heater bag line 128 and then pumped from the pump chambers 138A, 138B to the patient via the patient line 130. This flow path of the PD solution through the fluid pathways 158 in the cassette 112 is shown in
Once the PD solution has been pumped from the heater bag 124 to the patient, the PD solution is allowed to dwell within the patient for a period of time. During this dwell period, toxins cross the peritoneum into the PD solution from the patient's blood. As the PD solution dwells within the patient, the PD cycler 102 prepares fresh dialysate for delivery to the patient in a subsequent cycle. In particular, the PD cycler 102 pumps fresh PD solution from one of the four full PD solution bags 122 into the heater bag 124 for heating. To do this, the pump of the PD cycler 102 is activated to cause the piston heads 134A, 134B to reciprocate and certain inflatable members 142 of the PD cycler 102 are inflated to cause the PD solution to be drawn into the pump chambers 138A, 138B of the cassette 112 from the selected PD solution bag 122 via its associated line 126 and then pumped from the pump chambers 138A, 138B to the heater bag 124 via the heater bag line 128. This flow path of the PD solution through the fluid pathways 158 in the cassette 112 is shown in
After the PD solution has dwelled within the patient for the desired period of time, the spent PD solution is pumped from the patient to the drain. The heated PD solution is then pumped from the heater bag 124 to the patient where it dwells for a desired period of time. These steps are repeated with the PD solution from two of the three remaining PD solution bags 122. The PD solution from the last PD solution bag 122 is typically delivered to the patient and left in the patient until the subsequent PD treatment.
The PD cycler is typically used in an alternating pumping mode in which one piston head is protracted while the other piston head is retracted. Thus, as fluid drawn into one pumping chamber, fluid is simultaneously expelled from the other pumping chamber.
The adhesive attachment between the piston heads 134A, 134B and the membrane 140 can result in a substantially direct correlation between the position of the piston heads 134A, 134B and the volume of fluid drawn into and pumped out of the pump chambers 138A, 138B of the cassette 112. Such a direct correlation can improve the speed and accuracy of volumetric calculations of PD solution drawn into and pumped out of the cassette 112.
After completion of the PD treatment, the piston heads 134A, 134B are retracted away from the cassette 112 (e.g., perpendicular to the cassette 112) to a distance sufficient to allow the adhesive 161 to detach from the piston heads 134A, 134B and with a force that exceeds the adhesion strength or affinity of the adhesive 161 to the piston heads 134A, 134B. With this motion, the piston heads 134A, 134B become completely detached from the adhesive 161. Because the adhesion strength or affinity of the adhesive 161 to the membrane 140 is greater than the adhesion strength or affinity of the adhesive 161 to the piston heads 134A, 134B, the adhesive 161 remains adhered to the cassette 112 after the piston heads 134A, 134B have been detached. This helps to reduce or eliminate adhesive build-up on the piston heads 134A, 134B through repeated use. With the piston heads 134A, 134B detached from the adhesive 161, the door 108 of the PD cycler 102 is opened to expose the cassette 112, and the cassette 112, including the adhesive thereon, is removed from the cassette enclosure 114 by moving the bottom portion of the cassette 112 away from the cassette interface 110 and disengaging the top portion of the cassette 112 from the locating pins 148. In some cases, the cassette 112 is then discarded along with the fluid lines attached to the cassette 112. Because the adhesive 161 detaches from the piston heads 134A, 134B, it will generally be unnecessary for the user to clean the piston heads 134A, 134B prior to a subsequent use with a new cassette.
As shown in
Referring to
Referring to
While certain implementations have been described, other implementations are possible.
While the release paper 164 has been described as having a generally eyeglass shape, other types of release papers can be used. In some implementations, as shown in
While the release papers described above are shaped to cover substantially only those regions of the cassette membrane 140 that include adhesive thereon, the release paper can be dimensioned to cover any of various different areas of the cassette membrane 140. In some implementations, as shown in
While the adhesive 161 has been described as being initially disposed on the membrane 140 of the cassette 112, other arrangements are possible. In some implementations, for example, the adhesive 161 is initially disposed on the piston heads 134A, 134B. In certain implementations, the adhesive 161 remains on the piston heads 134A, 134B after the cassette 112 has been removed from the cassette enclosure 114 of the PD cycler 102. For example, the adhesive 161, the membrane 140 of the cassette 112, and the piston heads 134A, 134B can be formed of materials such that the adhesive 161 has a greater adhesion or affinity with the piston heads 134A, 134B than with the membrane 140. Because the adhesive 161 remains on the piston heads 134A, 134B, the adhesive 161 can be reused through multiple PD treatments, or the user can remove the adhesive 161 from the piston heads 134A, 134B between treatments. In other implementations, the materials of the adhesive 161, the membrane 140 of the cassette 112, and the piston heads 134A, 134B can be selected such that the adhesive 161 has a greater adhesion or affinity with the membrane 140 than with the piston heads 134A, 134B. In such cases, the adhesive 161 would ultimately remain adhered to the cassette 112 that is removed from the PD cycler 102 and discarded.
While the adhesive differential between the piston heads 134A, 134B and the membrane 140 has been described as being achieved through a combination of materials including forming the piston heads 134A, 134B of polyoxymethylene and the membrane 140 from the above-described multi-layer laminate while using a synthetic rubber adhesive, other material combinations that provide levels of adhesion between the adhesive and the piston heads and between the adhesive and the cassette membrane to allow the piston heads to retract the membrane during treatment and to allow the piston heads to be detached from the membrane after treatment without detaching the adhesive from the cassette membrane can be used.
In certain implementations, for example, the adhesive can be formed of any of various other types of materials that have adhesion properties similar to the synthetic rubber adhesive described above. For example, the adhesive can be a natural rubber adhesive or an acrylic adhesive. The piston heads 134A, 134B can be formed of one or more polyvinyl chlorides (PVC), polyamides, polycarbonates, ethyl vinyl acetates, and/or polysulfones. The membrane 140 can be formed of any of various types of polyolefins (e.g., high density polyethylenes (HDPE), low density polyethylenes (LDPE), or combinations of HDPE and LDPE) and/or polyvinylchlorides (PVC).
In certain implementations, the adhesive 161 is formed of natural rubber adhesive, the piston heads 134A, 134B are formed of polyoxymethylene plastic, and the membrane 140 is formed of polyolefin. In other implementations, the adhesive 161 is formed of acrylic co polymer, the piston heads 134A, 134B are formed of polycarbonate, and the membrane 140 is formed of PVC.
While the membrane 140 of the cassette 112 has been described as including three layers, the membrane of the cassette can alternatively include fewer than three layers. For example, the membrane can include two layers or only a single layer. Alternatively, the membrane of the cassette can include more than three layers.
While the base 156 of the cassette 112 has been described as being formed of polypropylene, the base 156 can be formed of any of various different rigid materials that are capable of being securely attached (e.g., thermally bonded, adhesively bonded) to the cassette membrane 140. In some implementations, for example, the base 156 is formed of polyvinyl chloride, polycarbonate, polysulfone, or other medical grade plastic materials.
While the piston heads 134A, 134B have been described as being formed of a single material that has a desired affinity for the adhesive, other types of piston head constructions can be used. For example, in some implementations, the piston head includes a core on which an outer layer or coating is applied. In such implementations, the outer layer or coating can be formed of a material that has the desired affinity for the adhesive while the core of the piston head can be formed of a different material that does not have the desired affinity for the adhesive. The outer layer or coating can, for example, be formed of any of the materials described above with regard to piston heads 134, 134B, and the core can be formed of any of various other materials, including polymers, metals, and/or alloys.
While the adhesion or affinity differential between the piston heads 134A, 134B and the membrane 140 has been described as being achieved through material selection, other methods of achieving the adhesion differential can alternatively or additionally be used. For example, the piston heads 134A, 134B can be roughened (e.g., through etching, through roughness built into a mold) to increase the surface area of the piston heads 134A, 134B. As compared to piston heads having smooth surfaces, such an increase in surface area can increase the adhesion between the adhesive 161 and the piston heads 134A, 134B and thus increase the types of materials that can be used for the piston heads 134A, 134B.
While the adhesive has been described as being applied in circular regions to the sheet of release paper before cutting the release paper into a desired shape (e.g., a generally eyeglass shape), in certain implementations, the adhesive is applied to (e.g., extruded onto) the sheet of release paper in a continuous layer. In such implementations, the adhesive would extend across the entire surface of the release paper/adhesive composite that is ultimately produced. In some implementations, the adhesive is not applied to an edge region of the sheet of release paper such that pull tabs of the release paper/adhesive composite can be cut from the edge region to facilitate removal of the release paper from the adhesive.
In certain cases, ready-to-use adhesive/release paper composites can be purchased from a supplier. In such cases, the release paper on one side of the adhesive would be removed from the composite and the exposed adhesive (with the other release paper secured to its opposite side) would be attached to the cassette membrane.
In some implementations, multiple layers of adhesive are used to releasably attach the piston heads 134A, 134B to the membrane 140. For example, as shown in
The use of two or more different adhesives allows the cassette to be used with membrane/piston head material combinations different than those discussed above. For example, multiple different adhesive combinations can be used for different dialysis systems.
While double-sided tape 500 has been described as including a base 96, the two different adhesives can be directly adhered to one another, particularly if each adhesive is biocompatible.
While the adhesive has been described as being uniformly distributed across those regions 162A, 162B of the cassette membrane 140 that overlie the pump chambers 138A, 138B, other arrangements are possible. For example, in some implementations, the adhesive 161 is distributed over the regions 162A, 162B in a pattern.
While the piston heads 134A, 134B have been described as being axially moved to break the attachment between the adhesive and the piston heads 134A, 134B, other types of movements of the piston heads 134A, 134B can alternatively or additionally be used to break the attachment between the adhesive and the piston heads 134A, 134B. In some implementations, each piston head is at least partially rotatable about an axis perpendicular to a membrane to detach the piston head from the adhesive through a substantially shear force. In certain implementations, each piston head is moveable in a direction substantially parallel to the membrane to detach the piston head from the adhesive through a substantially shear force. By allowing the release of the piston head using a different type of force than the one used to move the membrane, the likelihood of inadvertent detachment of the piston head can be reduced.
While the piston heads 134A, 134B have been described as being moved (e.g., retracted, rotated, and/or laterally displaced) by a distance sufficient to completely detach the piston heads 134A, 134B from the adhesive, the piston heads 134A, 134B can alternatively be moved by a distance that causes the piston heads 134A, 134B to only partially detach from the adhesive. In such implementations, the user can complete the detachment of the piston heads 134A, 134B from the adhesive when the user pulls the cassette out of the cassette enclosure of the PD cycler.
While the adhesive has been described as being exposed through the removal of a release paper, other methods of exposing the adhesive are possible. For example, the adhesive can be formed on the cassette 112 through the chemical reaction of two materials on the cassette 112. In such a configuration, a first non-adhesive material can be initially disposed on regions 162A, 162B of the cassette 112, and a second material can be placed into contact with the first material to form an adhesive.
While the cassette 112 has been described as being positioned between the locating pins 148 and the lower ledge 150 extending from the cassette interface 110 in order to hold the cassette 112 in a position such that the piston heads 134A, 134B align with the pump chambers 138A, 138B, other techniques for ensuring that the piston heads 134A, 134B align with the pump chambers 138A, 138B can alternatively or additionally be used. In some implementations, for example, the cassette 112 is placed against the door 108 of the PD cycler 102 with the hemispherical projections 154A, 154B of the cassette 112 disposed in the recesses 152A, 152B of the door 108. The cassette 112 is held in this position by retainer clips attached to the door 108. Upon closing the door 108, the piston heads 134A, 134B of the PD cycler 102 align with the pump chambers 138A, 138B of the cassette 112. This technique helps to prevent the adhesive 161 from inadvertently sticking to the piston heads 134A, 134B or the cassette interface 110 when loading the cassette 112 into the PD cycler 102.
While the PD cycler 102 has been described as including a touch screen and associated buttons, the PD cycler can include other types of screens and user data entry systems. In certain implementations, for example, the cycler includes a display screen with buttons (e.g., feathertouch buttons) arranged on the console adjacent the display screen. Certain buttons can be arranged to be aligned with operational options displayed on the screen during use such that the user can select a desired operational option by pressing the button aligned with that operational option. Additional buttons in the form of arrow buttons can also be provided to allow the user to navigate through the various display screens and/or the various items displayed on a particular screen. Other buttons can be in the form of a numerical keypad to allow the user to input numerical values in order, for example, to input operational parameters. A select or enter button can also be provided to allow the user to select an operational option to which the user navigated by using the arrow keys and/or to allow the user to enter values that the user inputted using the numerical keypad.
While the adhesive laden cassettes described above have been described as being part of a PD system, these types of cassettes can be used in any of various other types of cassette-based medical fluid pumping systems, including hemodialysis systems.
This application is a divisional of U.S. application Ser. No. 12/725,673, now U.S. Pat. No. 8,192,401 filed on Mar. 17, 2010, which claims the benefit under 35 U.S.C. §119(e) of U.S. Application Ser. No. 61/162,134, filed on Mar. 20, 2009. The above-referenced applications are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
329773 | Perry | Nov 1885 | A |
2383193 | Herbert | Aug 1945 | A |
2529028 | Landon | Nov 1950 | A |
2658526 | Porter | Nov 1953 | A |
2711134 | Hughes | Jun 1955 | A |
2755745 | Lewis | Jul 1956 | A |
2871795 | Smith | Feb 1959 | A |
2886281 | Canalizo | May 1959 | A |
3083943 | Stewart et al. | Apr 1963 | A |
3323786 | Boschi | Jun 1967 | A |
3556465 | Little | Jan 1971 | A |
3689025 | Kiser | Sep 1972 | A |
3741687 | Nystroem | Jun 1973 | A |
3927955 | Spinosa et al. | Dec 1975 | A |
3966358 | Heimes et al. | Jun 1976 | A |
3985135 | Carpenter et al. | Oct 1976 | A |
4026669 | Leonard et al. | May 1977 | A |
4047844 | Robinson | Sep 1977 | A |
4091812 | Helixon et al. | May 1978 | A |
4121584 | Turner et al. | Oct 1978 | A |
4152098 | Moody et al. | May 1979 | A |
4158530 | Bernstein | Jun 1979 | A |
4178940 | Au | Dec 1979 | A |
4273121 | Jassawalla | Jun 1981 | A |
4303376 | Siekmann | Dec 1981 | A |
4304260 | Turner et al. | Dec 1981 | A |
4322201 | Archibald | Mar 1982 | A |
4333452 | Au | Jun 1982 | A |
4370983 | Lichtenstein | Feb 1983 | A |
4382753 | Archibald | May 1983 | A |
4410322 | Archibald | Oct 1983 | A |
4412553 | Kopp et al. | Nov 1983 | A |
4436620 | Bellotti et al. | Mar 1984 | A |
4453932 | Pastrone | Jun 1984 | A |
4479760 | Bilstad et al. | Oct 1984 | A |
4479761 | Bilstad et al. | Oct 1984 | A |
4479762 | Bilstad et al. | Oct 1984 | A |
4490621 | Watabe et al. | Dec 1984 | A |
4536201 | Brorsson et al. | Aug 1985 | A |
4558715 | Walton et al. | Dec 1985 | A |
4569378 | Bergandy | Feb 1986 | A |
4583920 | Lindner | Apr 1986 | A |
4597412 | Stark | Jul 1986 | A |
4623328 | Hartranft | Nov 1986 | A |
4628499 | Hammett | Dec 1986 | A |
4639245 | Pastrone et al. | Jan 1987 | A |
4643713 | Viitala | Feb 1987 | A |
4657490 | Abbott | Apr 1987 | A |
4662598 | Weingarten | May 1987 | A |
4662906 | Matkovich et al. | May 1987 | A |
4676467 | Palsulich | Jun 1987 | A |
4690621 | Swain | Sep 1987 | A |
4703913 | Hunkapiller | Nov 1987 | A |
4705259 | Dolhen et al. | Nov 1987 | A |
4710166 | Thompson et al. | Dec 1987 | A |
4735558 | Kienholz et al. | Apr 1988 | A |
4778451 | Kamen | Oct 1988 | A |
4808161 | Kamen | Feb 1989 | A |
4826482 | Kamen | May 1989 | A |
4840542 | Abbott | Jun 1989 | A |
4842584 | Pastrone | Jun 1989 | A |
4846636 | Danby et al. | Jul 1989 | A |
4850980 | Lentz et al. | Jul 1989 | A |
4858883 | Webster | Aug 1989 | A |
4902282 | Bellotti et al. | Feb 1990 | A |
4906260 | Emheiser et al. | Mar 1990 | A |
4927411 | Pastrone et al. | May 1990 | A |
4950134 | Bailey et al. | Aug 1990 | A |
4974754 | Wirz | Dec 1990 | A |
4976162 | Kamen | Dec 1990 | A |
4995864 | Bartholomew et al. | Feb 1991 | A |
4997464 | Kopf | Mar 1991 | A |
5002471 | Perlov | Mar 1991 | A |
5006050 | Cooke et al. | Apr 1991 | A |
5036886 | Olsen et al. | Aug 1991 | A |
5061236 | Sutherland et al. | Oct 1991 | A |
5088515 | Kamen | Feb 1992 | A |
5098262 | Wecker et al. | Mar 1992 | A |
5100380 | Epstein | Mar 1992 | A |
5100699 | Roeser | Mar 1992 | A |
5116021 | Faust et al. | May 1992 | A |
5116316 | Sertic et al. | May 1992 | A |
5146713 | Grafius | Sep 1992 | A |
5151019 | Danby et al. | Sep 1992 | A |
5167837 | Snodgrass et al. | Dec 1992 | A |
5171029 | Maxwell et al. | Dec 1992 | A |
5178182 | Kamen | Jan 1993 | A |
5193990 | Kamen et al. | Mar 1993 | A |
5211201 | Kamen et al. | May 1993 | A |
5241985 | Faust et al. | Sep 1993 | A |
5247434 | Peterson et al. | Sep 1993 | A |
5249932 | Van Bork | Oct 1993 | A |
5252044 | Raines et al. | Oct 1993 | A |
5259352 | Gerhardy et al. | Nov 1993 | A |
5267956 | Beuchat | Dec 1993 | A |
5279556 | Goi et al. | Jan 1994 | A |
5302093 | Owens et al. | Apr 1994 | A |
5324422 | Colleran et al. | Jun 1994 | A |
5330425 | Utterberg | Jul 1994 | A |
5342182 | Montoya et al. | Aug 1994 | A |
5344292 | Rabenau et al. | Sep 1994 | A |
5350357 | Kamen et al. | Sep 1994 | A |
D351470 | Scherer et al. | Oct 1994 | S |
5353837 | Faust | Oct 1994 | A |
5378126 | Abrahamson et al. | Jan 1995 | A |
5395351 | Munsch | Mar 1995 | A |
5413626 | Bartsch | May 1995 | A |
5415528 | Ogden et al. | May 1995 | A |
5421208 | Packard et al. | Jun 1995 | A |
5421823 | Kamen et al. | Jun 1995 | A |
5427509 | Chapman et al. | Jun 1995 | A |
5431626 | Bryant et al. | Jul 1995 | A |
5431627 | Pastrone et al. | Jul 1995 | A |
5431634 | Brown | Jul 1995 | A |
5438510 | Bryant et al. | Aug 1995 | A |
5441636 | Chevallet et al. | Aug 1995 | A |
5445506 | Afflerbaugh et al. | Aug 1995 | A |
5447286 | Kamen et al. | Sep 1995 | A |
5462416 | Dennehey et al. | Oct 1995 | A |
5462417 | Chapman | Oct 1995 | A |
5474683 | Bryant et al. | Dec 1995 | A |
5478211 | Dominiak et al. | Dec 1995 | A |
5480294 | Di Perna et al. | Jan 1996 | A |
5482438 | Anderson et al. | Jan 1996 | A |
5482440 | Dennehey et al. | Jan 1996 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5484239 | Chapman et al. | Jan 1996 | A |
5486286 | Peterson et al. | Jan 1996 | A |
5514069 | Brown et al. | May 1996 | A |
5538405 | Patno et al. | Jul 1996 | A |
5540568 | Rosen et al. | Jul 1996 | A |
5547453 | Di Perna | Aug 1996 | A |
5551850 | Williamson et al. | Sep 1996 | A |
5551941 | Howell | Sep 1996 | A |
5551942 | Brown et al. | Sep 1996 | A |
5554013 | Owens et al. | Sep 1996 | A |
5570716 | Kamen et al. | Nov 1996 | A |
5573385 | Chevallier | Nov 1996 | A |
5578070 | Utterberg | Nov 1996 | A |
5588816 | Abbott et al. | Dec 1996 | A |
5593290 | Greisch et al. | Jan 1997 | A |
5609572 | Lang | Mar 1997 | A |
5614677 | Wamsiedler et al. | Mar 1997 | A |
5628908 | Kamen et al. | May 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5634896 | Bryant et al. | Jun 1997 | A |
5640995 | Packard et al. | Jun 1997 | A |
5641405 | Keshaviah et al. | Jun 1997 | A |
5641892 | Larkins et al. | Jun 1997 | A |
5643205 | Utterberg | Jul 1997 | A |
5645531 | Thompson et al. | Jul 1997 | A |
5658133 | Anderson et al. | Aug 1997 | A |
5669764 | Behringer et al. | Sep 1997 | A |
5690602 | Brown et al. | Nov 1997 | A |
D390654 | Alsberg et al. | Feb 1998 | S |
5713865 | Manning et al. | Feb 1998 | A |
5713888 | Neuenfeldt et al. | Feb 1998 | A |
5718567 | Rapp et al. | Feb 1998 | A |
5741125 | Neftel et al. | Apr 1998 | A |
5746708 | Giesler et al. | May 1998 | A |
5755683 | Houle et al. | May 1998 | A |
5764034 | Bowman et al. | Jun 1998 | A |
5769387 | Perez | Jun 1998 | A |
5771914 | Ling et al. | Jun 1998 | A |
5772635 | Dastur et al. | Jun 1998 | A |
5772637 | Heinzmann et al. | Jun 1998 | A |
5775371 | Pan et al. | Jul 1998 | A |
5782575 | Vincent et al. | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5799207 | Wang et al. | Aug 1998 | A |
5816779 | Lawless et al. | Oct 1998 | A |
5840151 | Munsch | Nov 1998 | A |
5842841 | Danby et al. | Dec 1998 | A |
5843035 | Bowman et al. | Dec 1998 | A |
5868696 | Giesler et al. | Feb 1999 | A |
5873853 | Keilman et al. | Feb 1999 | A |
5902096 | Behringer et al. | May 1999 | A |
5906598 | Giesler et al. | May 1999 | A |
5921951 | Morris | Jul 1999 | A |
5925011 | Faict et al. | Jul 1999 | A |
5934885 | Farrell et al. | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5938634 | Packard | Aug 1999 | A |
5984897 | Petersen et al. | Nov 1999 | A |
5989423 | Kamen | Nov 1999 | A |
5993174 | Konishi | Nov 1999 | A |
5996634 | Dennehey et al. | Dec 1999 | A |
6013057 | Danby et al. | Jan 2000 | A |
6036668 | Mathis | Mar 2000 | A |
6036680 | Horne et al. | Mar 2000 | A |
6041801 | Gray et al. | Mar 2000 | A |
6053191 | Hussey | Apr 2000 | A |
6065389 | Riedlinger | May 2000 | A |
6065941 | Gray et al. | May 2000 | A |
6068612 | Bowman et al. | May 2000 | A |
6074359 | Keshaviah et al. | Jun 2000 | A |
6079959 | Kingsford et al. | Jun 2000 | A |
6099492 | Le Boeuf | Aug 2000 | A |
6106246 | Steck et al. | Aug 2000 | A |
6110410 | Owens et al. | Aug 2000 | A |
6118207 | Ormerod et al. | Sep 2000 | A |
6129517 | Danby et al. | Oct 2000 | A |
6132187 | Ericson | Oct 2000 | A |
6136565 | Best et al. | Oct 2000 | A |
6152705 | Kennedy et al. | Nov 2000 | A |
6154605 | Aonuma | Nov 2000 | A |
6164621 | Bouchard et al. | Dec 2000 | A |
6165154 | Gray et al. | Dec 2000 | A |
6168394 | Forman et al. | Jan 2001 | B1 |
6178996 | Suzuki | Jan 2001 | B1 |
6179801 | Holmes et al. | Jan 2001 | B1 |
6184356 | Anderson et al. | Feb 2001 | B1 |
6189857 | Zeger et al. | Feb 2001 | B1 |
6196987 | Holmes et al. | Mar 2001 | B1 |
6200287 | Keller et al. | Mar 2001 | B1 |
6206644 | Pereira et al. | Mar 2001 | B1 |
6208107 | Maske et al. | Mar 2001 | B1 |
6210361 | Kamen et al. | Apr 2001 | B1 |
6220295 | Bouchard et al. | Apr 2001 | B1 |
6223130 | Gray et al. | Apr 2001 | B1 |
6227807 | Chase | May 2001 | B1 |
6227824 | Stehr | May 2001 | B1 |
6228047 | Dadson | May 2001 | B1 |
6229753 | Kono et al. | May 2001 | B1 |
6231537 | Holmes et al. | May 2001 | B1 |
6234989 | Brierton et al. | May 2001 | B1 |
6250502 | Cote et al. | Jun 2001 | B1 |
6261065 | Nayak et al. | Jul 2001 | B1 |
6267242 | Nagata et al. | Jul 2001 | B1 |
6270673 | Belt et al. | Aug 2001 | B1 |
6280406 | Dolecek et al. | Aug 2001 | B1 |
6281145 | Deguchi et al. | Aug 2001 | B1 |
6284142 | Muller | Sep 2001 | B1 |
6285155 | Maske et al. | Sep 2001 | B1 |
6286566 | Cline et al. | Sep 2001 | B1 |
6294094 | Muller et al. | Sep 2001 | B1 |
6296450 | Westberg et al. | Oct 2001 | B1 |
6297322 | Ding et al. | Oct 2001 | B1 |
6315707 | Smith et al. | Nov 2001 | B1 |
6315754 | Daoud et al. | Nov 2001 | B1 |
6316864 | Ormerod | Nov 2001 | B1 |
6322488 | Westberg et al. | Nov 2001 | B1 |
6325775 | Thom et al. | Dec 2001 | B1 |
6337049 | Tamari | Jan 2002 | B1 |
RE37553 | Ciavarini et al. | Feb 2002 | E |
6343614 | Gray et al. | Feb 2002 | B1 |
6348156 | Vishnoi et al. | Feb 2002 | B1 |
6361518 | Brierton et al. | Mar 2002 | B1 |
6364857 | Gray et al. | Apr 2002 | B1 |
6367669 | Au et al. | Apr 2002 | B1 |
6382923 | Gray | May 2002 | B1 |
6383158 | Utterberg | May 2002 | B1 |
6402486 | Steck et al. | Jun 2002 | B1 |
6406276 | Normand et al. | Jun 2002 | B1 |
6409696 | Toavs et al. | Jun 2002 | B1 |
6416293 | Bouchard et al. | Jul 2002 | B1 |
6419822 | Muller et al. | Jul 2002 | B2 |
6455676 | Weickert et al. | Sep 2002 | B1 |
6471855 | Odak et al. | Oct 2002 | B1 |
6481980 | Vandlik et al. | Nov 2002 | B1 |
6484383 | Herklotz | Nov 2002 | B1 |
6489896 | Platt et al. | Dec 2002 | B1 |
6491656 | Morris | Dec 2002 | B1 |
6494694 | Lawless et al. | Dec 2002 | B2 |
6497674 | Steele et al. | Dec 2002 | B1 |
6497676 | Childers et al. | Dec 2002 | B1 |
6503062 | Gray et al. | Jan 2003 | B1 |
6514225 | Utterberg et al. | Feb 2003 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
6520747 | Gray et al. | Feb 2003 | B2 |
6524231 | Westberg et al. | Feb 2003 | B1 |
6529573 | Olsher et al. | Mar 2003 | B2 |
6537445 | Muller | Mar 2003 | B2 |
6542761 | Jahn et al. | Apr 2003 | B1 |
6558343 | Neftel | May 2003 | B1 |
6572604 | Platt et al. | Jun 2003 | B1 |
6579253 | Burbank et al. | Jun 2003 | B1 |
6592542 | Childers et al. | Jul 2003 | B2 |
6595948 | Suzuki et al. | Jul 2003 | B2 |
6603229 | Toye, IV | Aug 2003 | B1 |
6604908 | Bryant et al. | Aug 2003 | B1 |
6645166 | Scheunert et al. | Nov 2003 | B2 |
6645177 | Shearn | Nov 2003 | B1 |
6648861 | Platt et al. | Nov 2003 | B2 |
6663359 | Gray | Dec 2003 | B2 |
6670323 | Looker et al. | Dec 2003 | B1 |
6672841 | Herklotz et al. | Jan 2004 | B1 |
6695593 | Steck et al. | Feb 2004 | B1 |
6695803 | Robinson et al. | Feb 2004 | B1 |
6709417 | Houle et al. | Mar 2004 | B1 |
6716004 | Vandlik et al. | Apr 2004 | B2 |
6723062 | Westberg et al. | Apr 2004 | B1 |
6725726 | Adolfs et al. | Apr 2004 | B1 |
6726656 | Kamen et al. | Apr 2004 | B2 |
6730055 | Bainbridge et al. | May 2004 | B2 |
6743201 | Dönig et al. | Jun 2004 | B1 |
6746514 | Bedingfield et al. | Jun 2004 | B2 |
6749403 | Bryant et al. | Jun 2004 | B2 |
6752172 | Lauer | Jun 2004 | B2 |
6752599 | Park | Jun 2004 | B2 |
6755801 | Utterberg et al. | Jun 2004 | B2 |
6758975 | Peabody et al. | Jul 2004 | B2 |
6759007 | Westberg et al. | Jul 2004 | B1 |
6759014 | Dales et al. | Jul 2004 | B2 |
6764460 | Dolecek et al. | Jul 2004 | B2 |
6764761 | Eu et al. | Jul 2004 | B2 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6774517 | Kowalski et al. | Aug 2004 | B2 |
6790014 | Bowen | Sep 2004 | B2 |
6790195 | Steele et al. | Sep 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6800054 | Westberg et al. | Oct 2004 | B2 |
6808369 | Gray et al. | Oct 2004 | B2 |
6814547 | Childers et al. | Nov 2004 | B2 |
6821432 | Metzner | Nov 2004 | B2 |
6828125 | Hoffman et al. | Dec 2004 | B1 |
6846161 | Kline et al. | Jan 2005 | B2 |
6852090 | Burbank et al. | Feb 2005 | B2 |
6869538 | Yu et al. | Mar 2005 | B2 |
6905479 | Bouchard et al. | Jun 2005 | B1 |
6929751 | Bowman, Jr. et al. | Aug 2005 | B2 |
6939111 | Huitt et al. | Sep 2005 | B2 |
6949079 | Westberg et al. | Sep 2005 | B1 |
6953323 | Childers et al. | Oct 2005 | B2 |
6957952 | Steck et al. | Oct 2005 | B1 |
6984218 | Nayak et al. | Jan 2006 | B2 |
7021148 | Kuhn et al. | Apr 2006 | B2 |
7029245 | Maianti et al. | Apr 2006 | B2 |
7033539 | Krensky et al. | Apr 2006 | B2 |
7041076 | Westberg et al. | May 2006 | B1 |
7044432 | Beden et al. | May 2006 | B2 |
7049406 | Weickert et al. | May 2006 | B2 |
7083719 | Bowman, Jr. et al. | Aug 2006 | B2 |
7087036 | Busby et al. | Aug 2006 | B2 |
7107837 | Lauman et al. | Sep 2006 | B2 |
7115107 | Delnevo et al. | Oct 2006 | B2 |
7115228 | Lundtveit et al. | Oct 2006 | B2 |
7147613 | Burbank et al. | Dec 2006 | B2 |
7153286 | Busby et al. | Dec 2006 | B2 |
7160087 | Fathallah et al. | Jan 2007 | B2 |
7166231 | Westberg et al. | Jan 2007 | B2 |
7175606 | Bowman, Jr. et al. | Feb 2007 | B2 |
7195607 | Westberg et al. | Mar 2007 | B2 |
7211560 | Looker et al. | May 2007 | B2 |
7232435 | Hildebrand et al. | Jun 2007 | B2 |
7236936 | White et al. | Jun 2007 | B2 |
7238164 | Childers et al. | Jul 2007 | B2 |
7255680 | Gharib | Aug 2007 | B1 |
7258534 | Fathallah et al. | Aug 2007 | B2 |
7261559 | Smith et al. | Aug 2007 | B2 |
7267661 | Susi | Sep 2007 | B2 |
7273465 | Ash | Sep 2007 | B2 |
7306578 | Gray et al. | Dec 2007 | B2 |
7331935 | Barere | Feb 2008 | B2 |
7338469 | Barker et al. | Mar 2008 | B2 |
7338472 | Shearn | Mar 2008 | B2 |
7345025 | Symonds et al. | Mar 2008 | B2 |
7347836 | Peterson et al. | Mar 2008 | B2 |
7390311 | Hildebrand et al. | Jun 2008 | B2 |
7398183 | Holland et al. | Jul 2008 | B2 |
7399637 | Wright et al. | Jul 2008 | B2 |
7404809 | Susi | Jul 2008 | B2 |
7410475 | Krensky et al. | Aug 2008 | B2 |
7422905 | Clague et al. | Sep 2008 | B2 |
7454314 | Holland et al. | Nov 2008 | B2 |
7461968 | Demers et al. | Dec 2008 | B2 |
7490021 | Holland et al. | Feb 2009 | B2 |
7500962 | Childers et al. | Mar 2009 | B2 |
7517387 | Chevallet et al. | Apr 2009 | B2 |
7553295 | Susi | Jun 2009 | B2 |
7556616 | Fathallah et al. | Jul 2009 | B2 |
7575564 | Childers | Aug 2009 | B2 |
7618948 | Kaemmerer | Nov 2009 | B2 |
7645258 | White et al. | Jan 2010 | B2 |
7648627 | Beden et al. | Jan 2010 | B2 |
7654976 | Peterson et al. | Feb 2010 | B2 |
7662286 | Childers et al. | Feb 2010 | B2 |
7699966 | Qin et al. | Apr 2010 | B2 |
7717682 | Orr | May 2010 | B2 |
7789849 | Busby et al. | Sep 2010 | B2 |
7815595 | Busby et al. | Oct 2010 | B2 |
8038640 | Orr | Oct 2011 | B2 |
8197231 | Orr | Jun 2012 | B2 |
8197439 | Wang et al. | Jun 2012 | B2 |
8206338 | Childers et al. | Jun 2012 | B2 |
8292594 | Tracey et al. | Oct 2012 | B2 |
8366921 | Beden et al. | Feb 2013 | B2 |
8409441 | Wilt | Apr 2013 | B2 |
8562834 | Kamen et al. | Oct 2013 | B2 |
8721879 | van der Marwe et al. | May 2014 | B2 |
20010034502 | Moberg | Oct 2001 | A1 |
20010037763 | Deguchi et al. | Nov 2001 | A1 |
20020045851 | King | Apr 2002 | A1 |
20020062109 | Lauer | May 2002 | A1 |
20020072718 | Brugger et al. | Jun 2002 | A1 |
20020107474 | Noack | Aug 2002 | A1 |
20020147423 | Burbank et al. | Oct 2002 | A1 |
20030018395 | Crnkovich et al. | Jan 2003 | A1 |
20030028144 | Duchon et al. | Feb 2003 | A1 |
20030029451 | Blair et al. | Feb 2003 | A1 |
20030042181 | Metzner | Mar 2003 | A1 |
20030100882 | Beden et al. | May 2003 | A1 |
20030136189 | Lauman et al. | Jul 2003 | A1 |
20030194332 | Jahn et al. | Oct 2003 | A1 |
20030200812 | Kuhn et al. | Oct 2003 | A1 |
20030204162 | Childers et al. | Oct 2003 | A1 |
20030217957 | Bowman et al. | Nov 2003 | A1 |
20030217961 | Hopping | Nov 2003 | A1 |
20030217975 | Yu et al. | Nov 2003 | A1 |
20030218623 | Krensky et al. | Nov 2003 | A1 |
20030220599 | Lundtveit et al. | Nov 2003 | A1 |
20030220605 | Bowman et al. | Nov 2003 | A1 |
20030220607 | Busby et al. | Nov 2003 | A1 |
20030220608 | Huitt et al. | Nov 2003 | A1 |
20030220609 | Childers et al. | Nov 2003 | A1 |
20030220627 | Distler et al. | Nov 2003 | A1 |
20040001766 | Maianti et al. | Jan 2004 | A1 |
20040010223 | Busby et al. | Jan 2004 | A1 |
20040019313 | Childers et al. | Jan 2004 | A1 |
20040019320 | Childers et al. | Jan 2004 | A1 |
20040031756 | Suzuki et al. | Feb 2004 | A1 |
20040064080 | Cruz et al. | Apr 2004 | A1 |
20040067161 | Axelsson | Apr 2004 | A1 |
20040082903 | Micheli | Apr 2004 | A1 |
20040084647 | Beden et al. | May 2004 | A1 |
20040109769 | Jahn et al. | Jun 2004 | A1 |
20040115068 | Hansen et al. | Jun 2004 | A1 |
20040135078 | Mandro et al. | Jul 2004 | A1 |
20040136843 | Jahn et al. | Jul 2004 | A1 |
20040156745 | Vandlik et al. | Aug 2004 | A1 |
20040195190 | Min et al. | Oct 2004 | A1 |
20040238416 | Burbank et al. | Dec 2004 | A1 |
20050054968 | Giannella | Mar 2005 | A1 |
20050230292 | Beden et al. | Oct 2005 | A1 |
20060002823 | Feldstein | Jan 2006 | A1 |
20060079766 | Neer et al. | Apr 2006 | A1 |
20060079826 | Beden et al. | Apr 2006 | A1 |
20060195064 | Plahey et al. | Aug 2006 | A1 |
20070112297 | Plahey et al. | May 2007 | A1 |
20070149913 | Busby et al. | Jun 2007 | A1 |
20070193940 | Duchamp et al. | Aug 2007 | A1 |
20070213651 | Busby et al. | Sep 2007 | A1 |
20070213653 | Childers et al. | Sep 2007 | A1 |
20070269340 | Dannenmaier et al. | Nov 2007 | A1 |
20070278155 | Lo et al. | Dec 2007 | A1 |
20080033346 | Childers et al. | Feb 2008 | A1 |
20080077068 | Orr | Mar 2008 | A1 |
20080125693 | Gavin et al. | May 2008 | A1 |
20080208103 | Demers et al. | Aug 2008 | A1 |
20080216898 | Grant et al. | Sep 2008 | A1 |
20080253912 | Demers et al. | Oct 2008 | A1 |
20090004033 | Demers et al. | Jan 2009 | A1 |
20090099498 | Demers et al. | Apr 2009 | A1 |
20090137940 | Orr | May 2009 | A1 |
20090169402 | Stenberg | Jul 2009 | A1 |
20090212248 | Kozak | Aug 2009 | A1 |
20100211044 | Dacquay et al. | Aug 2010 | A1 |
20100241062 | Morris et al. | Sep 2010 | A1 |
20100286614 | Ring | Nov 2010 | A1 |
20110015610 | Plahey et al. | Jan 2011 | A1 |
20110020156 | Van Brunt et al. | Jan 2011 | A1 |
20110092895 | Yardimci et al. | Apr 2011 | A1 |
20110125085 | McGill et al. | May 2011 | A1 |
20110137237 | Prisco et al. | Jun 2011 | A1 |
20110293450 | Grimes et al. | Dec 2011 | A1 |
20120065581 | Childers et al. | Mar 2012 | A1 |
20120123322 | Scarpaci et al. | May 2012 | A1 |
20120224984 | Orr | Sep 2012 | A1 |
20120230844 | Farrell et al. | Sep 2012 | A1 |
20120232469 | Medina | Sep 2012 | A1 |
20120271226 | Farrell et al. | Oct 2012 | A1 |
20120308412 | Rochat | Dec 2012 | A1 |
20130118961 | Beden et al. | May 2013 | A1 |
20130118970 | Beden et al. | May 2013 | A1 |
20130184638 | Scarpaci et al. | Jul 2013 | A1 |
20130330208 | Ly et al. | Dec 2013 | A1 |
20130331774 | Farrell et al. | Dec 2013 | A1 |
Number | Date | Country |
---|---|---|
2101232 | Jan 1983 | CA |
2628238 | Jan 1978 | DE |
2827648 | Jan 1979 | DE |
4006785 | Sep 1990 | DE |
4336336 | May 1994 | DE |
198 37 667 | Mar 2000 | DE |
19919572 | Nov 2000 | DE |
100 42 324 | Feb 2002 | DE |
100 46 651 | Apr 2002 | DE |
19919572 | Apr 2002 | DE |
100 53 441 | May 2002 | DE |
101 57 924 | May 2002 | DE |
69618766 | Aug 2002 | DE |
101 43 137 | Apr 2003 | DE |
102007059239 | Jun 2009 | DE |
0257279 | Mar 1988 | EP |
0314379 | Aug 1991 | EP |
0410125 | Aug 1993 | EP |
0728509 | Aug 1996 | EP |
0848193 | Jun 1998 | EP |
0 947 814 | Oct 1999 | EP |
0 956 876 | Nov 1999 | EP |
1529545 | May 2005 | EP |
1483702 | Aug 1977 | GB |
2331796 | Jun 1999 | GB |
0396850 | Apr 1991 | JP |
04-191755 | Jul 1992 | JP |
06-154314 | Jun 1994 | JP |
06-002650 | Nov 1994 | JP |
08028722 | Feb 1996 | JP |
11-347115 | Dec 1999 | JP |
2000-070358 | Mar 2000 | JP |
2000346214 | Dec 2000 | JP |
WO 8402473 | Jul 1984 | WO |
WO8601115 | Feb 1986 | WO |
WO9415660 | Jul 1994 | WO |
9420155 | Sep 1994 | WO |
WO9625064 | Sep 1996 | WO |
WO 9716214 | May 1997 | WO |
WO 9737703 | Oct 1997 | WO |
WO 9822165 | May 1998 | WO |
WO9822167 | May 1998 | WO |
WO 0023140 | Apr 2000 | WO |
WO 0033898 | Jun 2000 | WO |
WO 0117605 | Mar 2001 | WO |
0225146 | Mar 2002 | WO |
WO 0225225 | Mar 2002 | WO |
WO2007006030 | Jun 2007 | WO |
2009071069 | Jun 2009 | WO |
WO2009071069 | Jun 2009 | WO |
WO2011045167 | Apr 2011 | WO |
Entry |
---|
Gambro®, “DEHP-free cartridge blood sets,” © Nov. 2004, Gambro, Inc., Lakewood, CO, 4 pp. |
Gambro®, Prisma® HF 1000, “For Increased Filtration Capacity”, © Aug. 2001, Gambro Renal Products, Inc., Lakewood, CO, 2 pp. |
Gambro®, “Prisma® M60 and M100 Pre-Pump Infusion Sets—Introducing: The unique solution that enables Physicians to choose a predilution method that meets the needs of their patients”, © 2004, Gambro Inc., Lakewood, CO, 4 pp. |
Gambro®, “Prismaflex™ anticipating critical care needs and taking our innovative response . . . to new heights,” © 2004, Gambro Inc., Lakewood, CO, 8 pp. |
Glenn Avolio, “Principles of Rotary Optical Encoders,” Sensors Journal of Machine Perception, vol. 10, No. 4, pp. 10-18, 1993. |
Manns, Markus et al., “The acu-men: A new device for continuous renal replacement therapy in acute renal failure,” Kidney International, vol. 54, pp. 268-274, 1998. |
Liberty Cycler Operator's Manual, 2003-2004. |
Newton IQ Cycler Operator Manual, Part No. 470203 Rev. F, 2000-2006. |
Operator's Instructions, Fresenius 90/2 Peritoneal Therapy Cycler, Part No. 470016 Rev. B, 1991. |
Operator's Manual, Serena, Program Version 3.xx—English, 2002. |
Sleep Safe Operating Instructions, Software Version 0.9, Part No. 677 805 1; Aug. 2000. |
Sleep Safe Technical Manual, Part No. 677 807 1, Aug. 2000. |
Bolegoh, Gordon, “Pumps: Reference Guide”, p. 24, 3rd edition, 2001. |
Ronco et al., “Evolution of Machines for Automated Peritoneal Dialysis”, in Automated Peritoneal Dialysis, Contributions to Nephrology, vol. 129, pp. 142-161, 1999. |
Sleep Safe Operating Instructions, Software Version 0.5, Apr. 1999. |
Sleep Safe Operating Instructions, Software Version 1.0, Oct. 2000. |
Sleep Safe Technical Manual, Dec. 2001. |
Sleep Safe Operating Instructions, Jan. 2002. |
Sleep Safe Communicating Therapy, Mar. 1998. |
Sleep Safe Kommunizierte Therapie, May 1998. |
Innovative Technologies in Peritoneal Dialysis, Sleep Safe Concept, Oct. 13, 1999 (4 attachments). |
TL™ Pump Brochure, TL Systems Corporation. |
Number | Date | Country | |
---|---|---|---|
20120209169 A1 | Aug 2012 | US |
Number | Date | Country | |
---|---|---|---|
61162134 | Mar 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12725673 | Mar 2010 | US |
Child | 13454632 | US |